Search Results - "Manabe, Takushi"
-
1
Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
Published in Internal Medicine (01-09-2023)“…A patient with genotype 1b chronic hepatitis C virus who had been treated with pegylated interferon and ribavirin (RBV) was treated with…”
Get full text
Journal Article -
2
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
Published in Scientific reports (11-05-2024)“…Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on…”
Get full text
Journal Article -
3
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients
Published in BMC gastroenterology (01-04-2024)“…Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall…”
Get full text
Journal Article -
4
Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
Published in Diagnostics (Basel) (26-03-2023)“…Computed tomography (CT) is often used in the diagnosis of sarcopenia. In this study, we validated the assessment of sarcopenia by the psoas muscle volume…”
Get full text
Journal Article -
5
Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
Published in Internal Medicine (2023)“…A patient with genotype 1b chronic hepatitis C virus who had been treated with pegylated interferon and ribavirin (RBV) was treated with…”
Get full text
Journal Article -
6
Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy
Published in Cancers (18-03-2023)“…Sarcopenia-related factors, including the skeletal muscle index (SMI), are reportedly associated with prognosis in patients with hepatocellular carcinoma (HCC)…”
Get full text
Journal Article -
7
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy
Published in Cancers (19-06-2023)“…Although there have been advances in the prevention and diagnosis of hepatocellular carcinoma (HCC) in recent years, many HCC patients are still diagnosed with…”
Get full text
Journal Article